Accordingly, the improved TFS in female cases may be, at least in part, the consequence of a greater local exposure of leukemic cells to estrogens, described as tumor-suppressive molecules acting via the ER axis in cells of lymphoid origin that express ERβ [36]. This evidence concerns the gene ESR1 and neoplasm.